<DOC>
	<DOCNO>NCT00546546</DOCNO>
	<brief_summary>Pluricentric randomize study compare two therapeutic strategy begin Crohn 's disease : early immunosuppressant ( prescription within six first month follow diagnosis ) vs. conventional strategy ( immunosuppressant give case steroid failure , select group patient high risk disable course . The hypothesis immunosuppressant give early may improve disease course 3 follow year subset patient .</brief_summary>
	<brief_title>Early Immunosuppressants Crohn 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<mesh_term>Immunosuppressive Agents</mesh_term>
	<criteria>&gt; 18 yr old diagnosis Crohn 's disease intestinal lesion demonstrate last 6 month disease duration &lt; 6 month patient high risk disable disease ( 2 criterion 3 follow : age &lt; 40 , perinanal disease , steroid first flare ) prior prescription immunosuppressant severe course require early immunosuppressant ( steroid resistance , xtensive disease , disable perianal disease ) intestinal resection active infectious disease include HIV hepatic failure renal failure pregnancy high probability poor compliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Crohn</keyword>
	<keyword>immunosuppressant</keyword>
	<keyword>natural history</keyword>
	<keyword>steroid</keyword>
</DOC>